Interaction Guide · Research summary

Can I take Scutellaria Lateriflora with Clozapine?

Review Scutellaria Lateriflora with Clozapine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

There is not enough direct evidence to say that American skullcap increases sedation with clozapine. One small skullcap study found no reduction in energy or cognition, and another reported no adverse effects. Neither tested this combination, so these findings do not establish that co-use is safe.

What this answer covers

Scutellaria lateriflora (American skullcap) oral preparations, specifically characterized aerial-part extracts where stated. Scutellaria baicalensis and isolated flavonoids are distinct.

Supplement or preparation
Scutellaria lateriflora
Medication ingredient
clozapine

The direct interaction is uncertain

Clozapine can cause sedation, but that alone does not prove that every herb used for sleep adds to it. No direct clozapine and American skullcap clinical study was identified in the targeted search. The size and likelihood of an interaction remain unknown.

What the small studies found

A 43-person study reported improved mood without reduced energy or cognition. A later 66-person insomnia study reported better subjective sleep and no adverse effects with a characterized extract. Both had limitations, including carryover effects, and the later study excluded schizophrenia. Neither establishes clozapine combination safety.

American skullcap is a specific plant

These findings concern Scutellaria lateriflora. Chinese skullcap, Scutellaria baicalensis, is a different species, and an isolated constituent is a different exposure. The 2025 study used a defined aerial-part extract standardized to 10% baicalin; that result cannot automatically be assigned to every skullcap product.

Avoid assuming that unknown means safe

Discuss the exact product with the clozapine team before adding it for sleep. If you feel drowsy or unsteady, avoid driving and hazardous tasks and seek advice about troublesome symptoms. There is no established dose gap or clozapine dose change that resolves the evidence gap.

Evidence and practical considerations

Side effects & toxicity

An increased clozapine sedation or CNS-depression risk from American skullcap remains unestablished.

Exact scope
Scutellaria lateriflora (American skullcap) oral preparations, specifically characterized aerial-part extracts where stated. Scutellaria baicalensis and isolated flavonoids are distinct. with Oral clozapine, RxNorm 2626 IN.
Medication form and route
oral clozapine; oral botanical preparation

What remains uncertain

  • No clozapine co-use study; the insomnia trial excluded schizophrenia. Sleep improvement does not establish harmful additive sedation.

Factors that may matter: exact botanical preparation; other medicines; baseline drowsiness.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed clozapine.

Clozapine can cause sedation and impaired cognitive or motor performance; somnolence and instability can contribute to falls. Severe hepatotoxicity has been reported.

How this applies: Medication-specific safety context only; no direct botanical interaction or automatic dose change is established.

Does not name any of the six botanical counterparties or quantify their combined risks.

Source 2: randomized human trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 43 healthy participants, predominantly mildly anxious or less.

No significant between-treatment anxiety difference; mood improved without reduced energy or cognition.

How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.

Carryover and baseline group differences; no clozapine use. Findings do not prove absence of interaction.

Source 3: randomized human trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 66 adults with primary insomnia; schizophrenia and other psychiatric disorders excluded.

Subjective sleep outcomes improved and no adverse effects were reported.

How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.

Subjective endpoints, carryover effect, single center, product supplied free; no clozapine or schizophrenia applicability.

Research assessment: · Open full citations ↗

Side effects & toxicity

Skullcap trials reporting no reduced energy or cognition or no adverse effects cannot establish safety for people taking clozapine.

Exact scope
Scutellaria lateriflora (American skullcap) oral preparations, specifically characterized aerial-part extracts where stated. Scutellaria baicalensis and isolated flavonoids are distinct. with Oral clozapine, RxNorm 2626 IN.
Medication form and route
oral clozapine; oral botanical preparation

What remains uncertain

  • Small selected populations, carryover effects and different formulations; no pair-specific safety comparison.

Factors that may matter: exact botanical preparation; other medicines; baseline drowsiness.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: randomized human trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 43 healthy participants, predominantly mildly anxious or less.

No significant between-treatment anxiety difference; mood improved without reduced energy or cognition.

How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.

Carryover and baseline group differences; no clozapine use. Findings do not prove absence of interaction.

Source 2: randomized human trial

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 66 adults with primary insomnia; schizophrenia and other psychiatric disorders excluded.

Subjective sleep outcomes improved and no adverse effects were reported.

How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.

Subjective endpoints, carryover effect, single center, product supplied free; no clozapine or schizophrenia applicability.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Preparation-specific evidence and uncertainty assessed.
Clarified the study summary and formatted the original citation title for readability.
Research summary published

Article revision: 74b894c0c8f59973

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.